Shopping Cart
C57Bl/6 splenocytes were unstimulated (left panel) or stimulated for 3 days with LPS (right panel) and stained with 0.125 ug FITC Anti-Mouse CD86 (35-0862) (solid line) or 0.125 ug FITC Rat IgG2a isotype control (dashed line).

FITC Anti-Mouse CD86 (B7-2) (GL-1)

SKU 35-0862-U025
Regular price


task_alt Added to cart.
View Cart or Continue shopping.


The GL-1 antibody reacts with mouse CD86, also known as B7-2, an 80 kDa cell surface protein which is a ligand for CD28, a co-stimulatory receptor for the T cell receptor (TCR). CD28 can also bind a second B7 ligand known as CD80 (B7-1). Both CD80 and CD86 are expressed on activated B cells and antigen-presenting cells. These ligands trigger CD28 signaling in concert with TCR activation to drive T cell proliferation, induce high-level expression of IL-2, impart resistance to apoptosis, and enhance T cell cytotoxicity. The interaction / co-stimulatory signaling between ≥ ≥ ≥ the B7 ligands and CD28 provides crucial communication between ≥ ≥ ≥ T cells and B cells or APCs to coordinate the adaptive immune response.

The GL-1 antibody may be used as a marker for CD86 expression on B cells, macrophages, and dendritic cells.


Recent Citations:

Xu L, Su B, Mo L, Zhao C, Zhao Z, Li H, Hu Z, Li J. Norcantharidin Induces Immunogenic Cell Death of Bladder Cancer Cells through Promoting Autophagy in Acidic Culture. Int J Mol Sci. 2022 Apr 1;23(7):3944. doi: 10.3390/ijms23073944. PMID: 35409302; PMCID: PMC8999362. 

» View on PubMed

Name FITC Anti-Mouse CD86 (B7-2) (GL-1)
Cat. No. 35-0862
Alternative Names B7.2, B70, Ly-58
Gene ID 12524
Clone GL-1 (GL1)
Isotype Rat IgG2a, κ
Reactivity Mouse
Format FITC
Application Flow Cytometry
Price calculated at checkout.